Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, China.
Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, China.
J Clin Lab Anal. 2021 Dec;35(12):e24105. doi: 10.1002/jcla.24105. Epub 2021 Nov 9.
Thalassemia is a group of inherited autosomal recessive hemolytic anemia disease caused by reduced or absent synthesis of globin chain/chains of hemoglobin. Only few studies showed the molecular characterization of α- and β-thalassemia in Meizhou city of China.
A total of 22,401 individuals were collected; hematological and hemoglobin electrophoresis analysis and thalassemia genetic testing were performed.
Eleven thousand and thirty (49.24%) cases with microcytosis (mean corpuscular volume (MCV) < 82 fl), 11,074 (49.44%) cases with hypochromia (mean corpuscular Hb (MCH) < 27 pg) in 22,401 subjects, 11,085 cases with abnormal hemoglobin results were identified in subjects aged ≥6 months. 7,322 (32.69%) subjects harbored thalassemia mutations, including 4,841 (21.61%) subjects with α-thalassemia, 2,237 (9.99%) with β-thalassemia, and 244 (1.09%) with α-thalassemia combined β-thalassemia. 18 genotypes of α-thalassemia mutations and 27 genotypes of β-thalassemia mutations were characterized. The most frequent α gene mutation was -- (64.69%), followed by -α (19.93%), -α (7.73%), α α (3.97%), and α α (2.83%). The six most common β-thalassemia mutations were IVS-II-654 (C>T) (39.79%), CD41-42 (-TCTT) (33.02%), -28 (A>G) (10.38%), CD17 (A>T) (9.08%), CD27-28 (+C) (2.14%), and CD26 (G>A) (2.02%). In addition, MCV and MCH were sensitive markers for α- and β-thalassemia except for -α /αα, -α /αα, α α/αα, α α/αα, and β /β .
The -- , -α , and -α deletions were the main mutations of α-thalassemia, while IVS-II-654 (C>T), CD41-42 (-TCTT), -28 (A>G), and CD17 (A>T) mutations of β-thalassemia in Meizhou. There were some differences in thalassemia mutation frequencies in Meizhou city from other populations in China.
地中海贫血是一组由珠蛋白链/血红蛋白链合成减少或缺失引起的遗传性常染色体隐性溶血性贫血疾病。只有少数研究显示了中国梅州市的α-和β-地中海贫血的分子特征。
共收集 22401 人;进行血液学和血红蛋白电泳分析以及地中海贫血基因检测。
在 22401 名受试者中,有 11030 名(49.24%)存在小细胞症(平均红细胞体积(MCV)<82fl),11074 名(49.44%)存在低色素性(平均红细胞 Hb(MCH)<27pg),在年龄≥6 个月的受试者中发现 11085 例异常血红蛋白结果。7322 例(32.69%)受试者携带有地中海贫血突变,包括 4841 例(21.61%)α-地中海贫血,2237 例(9.99%)β-地中海贫血,244 例(1.09%)α-地中海贫血合并β-地中海贫血。鉴定出 18 种α-地中海贫血突变和 27 种β-地中海贫血突变。最常见的α基因突变是--(64.69%),其次是-α(19.93%)、-α(7.73%)、αα(3.97%)和αα(2.83%)。六种最常见的β-地中海贫血突变是 IVS-II-654(C>T)(39.79%)、CD41-42(-TCTT)(33.02%)、-28(A>G)(10.38%)、CD17(A>T)(9.08%)、CD27-28(+C)(2.14%)和 CD26(G>A)(2.02%)。此外,MCV 和 MCH 除了-α/αα、-α/αα、αα/αα、αα/αα 和-β/β之外,是α-和β-地中海贫血的敏感标志物。
在梅州市,-、-α 和-α 缺失是α-地中海贫血的主要突变,而 IVS-II-654(C>T)、CD41-42(-TCTT)、-28(A>G)和 CD17(A>T)突变是β-地中海贫血的主要突变。梅州市地中海贫血突变频率与中国其他人群存在一些差异。